Clinical Trial Update: Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial [Phase 3]

View source ↗

Summary

Multicenter Phase 3 randomized, active-controlled trial evaluating a short-course regimen for low-risk active pulmonary tuberculosis. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: RECRUITING